Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Baxter
Medtronic
McKesson
Johnson and Johnson
Colorcon
Harvard Business School

Last Updated: May 26, 2022

CLINICAL TRIALS PROFILE FOR PROAIR HFA


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Proair Hfa

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00530062 ↗ Comparison of Single-Dose of Albuterol Breath Activated Inhaler Versus Albuterol Metered Dose Inhaler in Asthmatics Completed Teva Branded Pharmaceutical Products R&D, Inc. Phase 4 2007-01-01 This is a research study designed to compare the single-dose effectiveness of albuterol-HFA-BAI (breath activated inhaler) and albuterol-HFA-MDI (metered dose inhaler) in asthmatics with poor inhaler coordinating abilities. Patients must be 7 to 70 years of age to participate in this study.
NCT00530062 ↗ Comparison of Single-Dose of Albuterol Breath Activated Inhaler Versus Albuterol Metered Dose Inhaler in Asthmatics Completed Teva Branded Pharmaceutical Products, R&D Inc. Phase 4 2007-01-01 This is a research study designed to compare the single-dose effectiveness of albuterol-HFA-BAI (breath activated inhaler) and albuterol-HFA-MDI (metered dose inhaler) in asthmatics with poor inhaler coordinating abilities. Patients must be 7 to 70 years of age to participate in this study.
NCT00588406 ↗ Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room. Completed AstraZeneca Phase 3 2007-09-01 To determine whether adding nebulized inhaled steroids to the standard care of acutely ill ED patients with refractory acute asthma helps improve forced expiratory volume at one second (FEV1) and decrease the need for hospitalization.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Proair Hfa

Condition Name

Condition Name for Proair Hfa
Intervention Trials
Asthma 7
Healthy 2
Bronchopulmonary Dysplasia 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Proair Hfa
Intervention Trials
Asthma 8
Respiratory Aspiration 2
Lung Diseases, Obstructive 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Proair Hfa

Trials by Country

Trials by Country for Proair Hfa
Location Trials
United States 39
Taiwan 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Proair Hfa
Location Trials
California 5
North Carolina 4
Florida 4
Oregon 4
Oklahoma 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Proair Hfa

Clinical Trial Phase

Clinical Trial Phase for Proair Hfa
Clinical Trial Phase Trials
Phase 4 3
Phase 3 3
Phase 2 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Proair Hfa
Clinical Trial Phase Trials
Completed 7
Active, not recruiting 3
Recruiting 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Proair Hfa

Sponsor Name

Sponsor Name for Proair Hfa
Sponsor Trials
Teva Branded Pharmaceutical Products R&D, Inc. 5
Teva Branded Pharmaceutical Products, R&D Inc. 3
Intech Biopharm Ltd. 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Proair Hfa
Sponsor Trials
Industry 15
Other 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Harvard Business School
McKinsey
Mallinckrodt
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.